[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100528449":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":42,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":10,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Xinjiang Medical University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"2",null,[12],"Other: Standard therapy",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"Standard therapy","Individualized blood pressure reduction program",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Xiang Xie, Phd","CONTACT","15099169036","xiangxie999@sina.com",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"The First Affiliated Hospital of Xinjiang Medicial University","RECRUITING","Ürümqi","Xinjiang","830000","China","CN",{"type":34,"coordinates":35},"Point",[36,37],87.60046,43.80096,{"lat":37,"lon":36},[40],{"name":41,"role":21,"phone":22,"phoneExt":10,"email":23},"Xiang xie, PHD",{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Xiang Xie","Xiangxie, MD,The First Affiliated Hospital Of XinJiang Medicial University","100528449","prognostic-model-of-hypertension-100528449",false,"NCT06160921","Prognostic Model of Hypertension","PHOP-HT","Inclusion Criteria:\n\n* A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University\n\nExclusion Criteria:\n\n* Patients with secondary hypertension, patients with liver and kidney dysfunction,\n* patients with mental disorders, and patients who are unwilling to participate in this trial","ALL",{"count":55,"type":56},50000,"ESTIMATED","OBSERVATIONAL","The aim of this study was to establish a registration and monitoring system for hypertension in Xinjiang from 2020 to 2030 to obtain real information about patient basic information, patient characteristics, diagnostic test patterns, treatment options, and hospitalization outcomes (including mortality). Treatment complications, hospitalization costs, and end-of-life events (death, major adverse cardiac events, mild adverse cardiovascular events) in patients with hypertension in Xinjiang; and scientific prevention strategies aimed at effectively preventing the onset of hypertension; Guidelines in clinical practice recommend, analyze and develop effective treatment strategies to optimize management and outcomes for patients with hypertension; and create cost-effective assessment systems.",[60],"Hypertension","2024-03-26",{"date":63,"type":64},"2024-03-28","ACTUAL",{"date":66,"type":64},"2020-01-01",{"date":68,"type":56},"2030-01-01",{"name":5,"class":6},1]